Skip to main content

Intravenous immunoglobulins as first-line therapy for IgLON5 encephalopathy

Journal of Neurology volume 266, pages 1031–1033 (2019)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Simabukuro MM, Sabater L, Adoni T et al (2015) Sleep disorder, chorea, and dementia associated with IgLON5 antibodies. Neurol Neuroimmunol Neuroinflamm 2:e136

    Article  PubMed  PubMed Central  Google Scholar 

  2. Gaig C, Graus F, Compta Y et al (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88:1736–1743

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sabater L, Gaig C, Gelpi E et al (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13:575–586

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Honorat JA, Komorowski L, Jacobs KA et al (2017) IgLON5 antibody. Neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm 4:e385

    Article  PubMed  PubMed Central  Google Scholar 

  5. Haitao R, Yingmai Y, Yan H et al (2016) Chorea and parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy. J Neuroimmunol 300:9–10

    Article  CAS  PubMed  Google Scholar 

  6. Bonello M, Jacob A, Ellul MA et al (2017) IgLON5 disease responsive to immunotherapy. Neurol Neuroimmunol Neuroinflamm 4:e383

    Article  PubMed  PubMed Central  Google Scholar 

  7. Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with Anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12(2):157–165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Irani SR, Stagg CJ, Schott JM et al (2013) Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 136(Pt 10):3151–3162

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank J Enczmann for testing the HLA types of the patient and for giving the permission for publishing these results.

Author information

Affiliations

  1. Department of Neurology, Medical Faculty, Heinrich-Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany

    K. Logmin, A. S. Moldovan, S. Elben, A. Schnitzler & S. J. Groiss

  2. Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany

    A. S. Moldovan, S. Elben, A. Schnitzler & S. J. Groiss

Authors
  1. K. Logmin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. S. Moldovan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Elben
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Schnitzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. J. Groiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. J. Groiss.

Ethics declarations

Conflicts of interest

The authors have no conflicts of interests to report.

Ethical standards

The study was performed in accordance with the Declaration of Helsinki.

Informed consent

The patient gave his consent to publish the case report.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Logmin, K., Moldovan, A.S., Elben, S. et al. Intravenous immunoglobulins as first-line therapy for IgLON5 encephalopathy. J Neurol 266, 1031–1033 (2019). https://doi.org/10.1007/s00415-019-09221-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-019-09221-3